Want to see JP:3148 full AI Analyst Report?
Top Page
Create SD Holdings Co., Ltd.
(3148)
Select Model
Select Model
Rating:75Outperform
Price Target:
¥3,690.00
▲(10.48% Upside)
Action:Reiterated
Date:07/14/26
The score is driven primarily by strong financial stability (especially the very conservative balance sheet) and a reasonable valuation with a supportive dividend. Technical signals are mildly constructive but not strongly bullish, and cash-flow conversion volatility remains the key financial watch item.
Positive Factors
Very conservative balance sheet
Extremely low leverage and steadily compounding equity give the company durable financial flexibility. This reduces refinancing and interest-rate risks, supports capital allocation to stores, acquisitions or dividends, and materially increases resilience through economic cycles.
Negative Factors
Volatile free cash flow conversion
Inconsistent conversion of accounting profits into discretionary cash constrains the company's ability to fund capex, expand stores, or boost dividends without external financing. Persistent variability suggests working-capital or timing exposures that limit strategic optionality.
Read all positive and negative factors
Positive Factors
Negative Factors
Very conservative balance sheet
Extremely low leverage and steadily compounding equity give the company durable financial flexibility. This reduces refinancing and interest-rate risks, supports capital allocation to stores, acquisitions or dividends, and materially increases resilience through economic cycles.
Read all positive factors
Create SD Holdings Co., Ltd. (3148) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥211.15B
Dividend Yield2.35%
Average Volume (3M)76.12K
Price to Earnings (P/E)12.7
Beta (1Y)0.25
Revenue Growth8.76%
EPS Growth8.19%
CountryJP
Employees5,060
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)258.59
Shares Outstanding66,819,340
10 Day Avg. Volume114,270
30 Day Avg. Volume76,116
Financial Highlights & Ratios
PEG Ratio1.47
Price to Book (P/B)1.35
Price to Sales (P/S)0.42
P/FCF Ratio22.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Create SD Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Create SD Holdings Co., Ltd., along with its various subsidiaries, conducts business in Japan across the drugstore, pharmacy, and nursing care sectors. Its retail operations provide a broad array of products, including pharmaceuticals, cosmetics, ...
How the Company Makes Money
The company primarily makes money through (1) retail sales at its drugstore network—revenue generated from selling over-the-counter medicines, health and beauty products, and everyday consumer goods—and (2) dispensing/pharmacy operations—revenue g...
Create SD Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
62
Positive
| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 483.84B | 497.13B | 457.09B | 422.33B | 380.96B | 350.74B |
| Gross Profit | 122.99B | 120.87B | 119.22B | 110.19B | 102.99B | 95.58B |
| EBITDA | 29.57B | 30.53B | 27.66B | 24.35B | 23.01B | 22.02B |
| Net Income | 16.70B | 16.99B | 15.69B | 13.69B | 12.93B | 12.60B |
Balance Sheet | ||||||
| Total Assets | 241.43B | 255.35B | 236.56B | 216.48B | 194.94B | 176.91B |
| Cash, Cash Equivalents and Short-Term Investments | 31.08B | 37.10B | 37.75B | 38.21B | 37.53B | 42.07B |
| Total Debt | 1.67B | 1.36B | 0.00 | 1.00M | 6.00M | 25.00M |
| Total Liabilities | 92.34B | 101.03B | 93.84B | 86.24B | 78.53B | 70.58B |
| Stockholders Equity | 149.09B | 154.32B | 142.72B | 130.24B | 116.41B | 106.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.22B | 6.10B | 5.26B | 3.03B | 8.63B |
| Operating Cash Flow | 0.00 | 25.43B | 23.63B | 21.03B | 18.98B | 16.10B |
| Investing Cash Flow | 0.00 | -20.41B | -20.70B | -20.21B | -20.49B | -10.81B |
| Financing Cash Flow | 0.00 | -5.68B | -3.39B | -140.00M | -3.03B | -2.91B |
Create SD Holdings Co., Ltd. Technical Analysis
Positive
3340.00
Price Trends
3245.10
Positive
3241.78
Positive
3230.20
Positive
Market Momentum
31.84
Negative
55.50
Neutral
68.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3148, the sentiment is Positive. The current price of 3340 is above the 20-day moving average (MA) of 3290.25, above the 50-day MA of 3245.10, and above the 200-day MA of 3230.20, indicating a bullish trend. The MACD of 31.84 indicates Negative momentum. The RSI at 55.50 is Neutral, neither overbought nor oversold. The STOCH value of 68.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3148.
Create SD Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥211.15B | 12.70 | ― | 2.35% | 8.76% | 8.19% | |
68 Neutral | ¥452.14B | 14.41 | 11.37% | 3.04% | 5.08% | 2.07% | |
67 Neutral | ¥557.04B | 17.45 | 15.71% | 0.96% | 12.20% | -25.42% | |
64 Neutral | ¥513.26B | 15.95 | ― | 0.93% | 8.72% | 3.45% | |
62 Neutral | ¥1.07T | 18.51 | ― | 1.72% | ― | ― | |
54 Neutral | ¥369.65B | 21.81 | ― | 0.41% | 13.04% | 0.30% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3148
Create SD Holdings Co., Ltd.
3,340.00
-55.07
-1.62%
JP:9989
Sundrug Co
3,867.00
-570.37
-12.85%
JP:7649
Sugi Holdings Co
2,955.50
-701.51
-19.18%
JP:3391
TSURUHA Holdings
2,381.00
108.48
4.77%
JP:3349
COSMOS Pharmaceutical Corporation
6,448.00
-2,677.97
-29.34%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,866.00
-56.39
-1.44%
Create SD Holdings Co., Ltd. Corporate Events
Create SD Holdings Raises Annual Dividend to ¥93, Deepening Shareholder Focus
Jul 13, 2026
Create SD Holdings Co., Ltd., a Prime Market-listed Japanese retailer centered on drugstores and consumer services, maintains a capital policy that stresses stable and rising dividends. The company uses payout and equity-based metrics to align sha...
Create SD Holdings Posts Higher Earnings and Lifts Dividend as Sales Climb
Jul 13, 2026
Create SD Holdings reported consolidated net sales of ¥497.1 billion for the fiscal year ended May 31, 2026, up 8.8% year on year, with operating profit rising 5.9% to ¥24.0 billion and profit attributable to owners of parent climbing 8....
Create SD Holdings to Consolidate Leadership with New Representative Structure
Jun 22, 2026
Create SD Holdings Co., Ltd. has announced planned changes to its top management structure, with the Board of Directors resolving to alter representative roles at both the holding company and its core subsidiary, Create SD Co., Ltd. The moves, sch...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.